ACute and Chronic Effects of Saxagliptin

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions

Impaired Glucose Tolerance

Interventions

DRUG

saxagliptin

5mg a day for 11-14 weeks

OTHER

placebo pill

one tablet a day for 11-14 weeks

Trial Locations (1)

Jean Verdier hospital, Department of Endocrinology-Diabetology-Nutrition, Bondy

All Listed Sponsors

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT01521312 - ACute and Chronic Effects of Saxagliptin | Biotech Hunter | Biotech Hunter